Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly! Immu-Moron May be closed. IMRNW strike prices are $10.8 while IMRN is only $2,8 currently, so, IMRNW is worth of -$8 (minus $8)! Can’t believe that Some idiots are buying this shhhittt which is not even worth of toilet paper. Lol!
🇺🇸 The US Department of Defense has reported that @ImmuronLtd's $IMC Travelan® product demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia, indicating broad potential for prevention of travellers' diarrhea: https://t.co/gYsp3WYl4Kpic.twitter.com/x7uYaIjYs0
Immuron has 4 ongoing Phase 2 trials. 3 Phase trials in NASH in progress, and another blockbuster indication Cdiff (Better product than $MCRB imo) Of the NASH trials, two of which were selected to be fully funded by the National Institute of Health. Alcoholic fatty liver disease, Non alcoholic fatty liver disease, Pedriatric fatty liver disease. Dr Arun Sanyal is Chair of NIH NASH Clinical Research network and an Advisory board member to Immuron. https://www.bloomberg.com/research/stocks/people/person.asp?personId=60481092&privcapId=7687411